IGR Cancer Therapeutics and Supportive Care Drugs Mark | Page 2

The report on Cancer Therapeutics and Supportive Care Drugs Market by type (cancer therapeutics,
supportive care drugs), by distribution channel (hospital, retail) trends analysis and forecasts up to 2023
studies the market sizes, key trends and opportunities in the main geographies such as North America,
Europe, Asia-Pacific, Rest of the World. According to the report the Global Cancer Therapeutics and
Supportive Care Drugs Market is projected to grow at a CAGR of 9.7% in terms of value over the period of
2017-2023. The growth in the world market is primarily driven by significant contribution by North America
(Leading region) region to this market.
Get Sample Copy of this Report:-
https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/22
New treatment options have become available in the past five years, and the surge of innovation is expected
to continue due to a robust pipeline of drugs in clinical development by a large and diverse group of
pharmaceutical companies. Innovations in the development of new drugs and therapies, large number of
new drugs entering into the market with FDA approval, increasing prevalence of cancerous patients,
availability of new treatment options in the market and rise in base of aging population are the key driving
factors for the growth of this market. In addition, changing lifestyle habits of populations, increased patient’s
healthcare awareness, and increasing demand for non-invasive therapies are further expected to propel the
market growth in the coming years. Along with these driving factors, the market for cancer therapeutics is
facing some challenges such as time consuming regulatory compliance and high cost of cancer drugs.
However, the market for cancer therapeutics and supportive care drugs is likely to rise in the future due to
the large number of ongoing innovations for the treatment of cancer.
Geographically, North America is the leading contributor to the market and is expected to retain its position
during the forecast period due to high awareness, presence of large base of cancer patients, rise in
Infinium Global Research